Ascendis Pharma A Net Income per Employee (ASND), current and historic results, rankings and more, Quarterly Fundamentals - CSIMarket
CSIMarket
 


Ascendis Pharma A  (NASDAQ: ASND)
 

Ascendis Pharma A Net Income per Employee

ASND's Quarterly Results, Trends, Rankings, Statistics
Ascendis Pharma A recorded a cumulative net loss of $-258 million during 12 month ending in the fourth quarter 2025.
The Healthcare sector has seen employees of 441 other companies achieving higher income per employee. While Ascendis Pharma A's total ranking has deteriorated compared to the previous quarter from 0 to 4570.


What is Income per Employee Ratio?






ASND Net Income per Employee (Dec 31 2025)
IV. Quarter
0
III. Quarter
0
II. Quarter
0
I. Quarter
(Dec 31 2024)
IV. Quarter
Y / Y Net Income Change - - - - -
Net Income per Employee (TTM) $ -2,578,202 -2,550,917 -2,928,101 -3,664,997 -4,090,868
ASND's Total Ranking # 4570 # 0 # # #
Seq. Net Income Change - - - - -


ASND Net Income per Employee Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry # 442
Healthcare Sector # 936
Overall Market # 4570

Net Income per Employee Statistics
High Average Low
$ -1,457,086 $ -3,743,931 $ -6,531,773
(Dec 31 2018)   (Dec 31 2022)







Companies with similar Income per Employee for 12 month ending Dec 31 2025, within Healthcare Sector Income per Employee Income 12 month ending Dec 31 2025Number of Employees Dec 31 2025


Date modified: 2026-09-08T16:36:48+00:00




Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.